Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive deterioration of cognition and memory, in which oxidative stress has been played a crucial role in the pathology of AD. Electroacupuncture (EA) is a widely used therapy based on traditional acupuncture combined with modern electrotherapy in Asia. The present study aimed to determine the effects of EA treatment on spatial learning and memory impairment, and to elucidate the status of NOX2-related oxidative stress in a rat model of Alzheimer's disease induced by Beta-amyloid 1-42 (Aβ 1-42 ). Fifty-six adult female Sprague-Dawley (SD) rats were randomly divided into four groups: sham, sham+EA, AD and AD+EA. The rats in Sham+EA and AD+EA groups were respectively administrated EA treatment at Baihui and yongquan acupoints, once a day for 30 min, lasting for 28 days. The spatial learning and memory functions were assessed by Morris water maze (MWM) test. The activities of total antioxidant capacity (T-AOC), reactive oxygen species (ROS), malondialdehyde (MDA) and 8-hydroxy-2-deoxyguanosine (8-OH-dG) were evaluated. Moreover, the neuronal injury was detected by Nissl staining. Meanwhile, the NeuN expression was examined in the hippocampus, the expression levels of Nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase2(NOX2) was detected by immunofluorescence staining and western blot. The results showed that EA treatment significantly improved spatial learning and memory impairment in rats induced by Aβ 1-42 . Concomitantly, EA treatment markedly restored T-AOC and attenuated the abnormal increase in levels of ROS, MDA and 8-OH-dG in the hippocampus of the AD rats. More notably, EA treatment also effectively ameliorated neuronal injury and counteracted the aberrant increase of NOX2 levels in the hippocampus of AD rats. Our findings suggested that EA is a potential strategy for the treatment of AD, and the possible mechanism is associated with the alleviation of neuronal injury and inhibition of NOX2-related oxidative stress.
Introduction
Alzheimer's disease (AD) is an age-dependent progressive and insidious neurodegenerative disorder marked by deficits in cognitive function. The neuropathology of AD is characterized by extracellular amyloid beta protein (Aβ) deposition, and neuro-fibrillary tangles-associated alteration of neuronal networks. Although several other hypotheses have been proffered to explain the changes in complex pathophysiological conditions of AD, such as amyloid cascade, excitoxicity and inflammation, oxidative stress remains the most convincing explanation (1) . The accumulated evidence indicates that extracellular Aβ peptide deposition causes an increase in intracellular reactive oxygen species (ROS) (2) . The over generation of ROS results in structural and functional cell damage through lipid peroxidation and DNA damage (3) . With so many of these harmful events in cells, oxidative stress involved in the pathogenesis of AD (4) .
ROS can be generated in multiple intracellular compartments and regulated by multiple enzymes in cells. Nicotinamide adenine dinucleotide phosphate (NA-DPH) oxidase, an expanding family of ROS-generating enzymes including NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1 and DUOX2, which share the capacity to transport electrons across the plasma membrane and to generate superoxide and other downstream ROS (5, 6) . The activity of gp91phox, which is a catalytic subunit of NOX2, is strongly associated with ROS production (7) . A recent study revealed that NOX2-derived ROS contributed to cognitive impairments induced by surgery in aged-mice (8) . Another study found that inhibition of NOX2 could attenuate hydrogen peroxide-induced oxidative stress in HT22 cells (9) .
Electroacupuncture (EA) treatment is a type of needling therapy, which combines traditional needling with electric stimulation. Clinically, EA treatment has been shown to have efficacy in curing many kinds of neurological diseases, such as depression (10, 11) , cerebral ischemia-reperfusion injury (12) and stroke (13) (14) (15) . It was reported that EA treatments accelerated the improvement of cognitive impairment in vascular dementia and ischemia-reperfusion injury in vivo experiments (16, 17) . Repeated EA treatment could ameliorate spatial reference memory impairment in APP/PS1 double transgenic mice (12) . While reviewing ancient Chinese documents regarding acupuncture and cognitive impairment, we discovered the GV20 and KI1 were the most frequently selected acupoints for treatment men-Cell Mol Biol (Noisy le Grand) 2017 | Volume 63 | Issue 4 G. Wu et al. tal disorders in China (16, 18, 19) . Baihui (GV20; on the anterior midline in front of boundary of the frontal and parietal bones) and Yongquan (KI1; on center of the posterior palm) plays an important role in the nervous system. The GV20 acupoint is recognized to be involved in the improvement of headache, dizziness, fainting, and the K11 is involved in adjustment of memory function. Thus, using with an AD rat model induced by Beta-amyloid 1-42 (Aβ 1-42 ) intracerebroventrical injection, we expect to investigate whether EA treatment on GV20 and KI1 acupoints could improve spatial learning and memory impairment, and to explore the association of the potential therapeutic effects with inhibition of NOX2-related oxidative stress in AD rats.
Materials and Methods

Animals and groups
Fifty-six nulliparous female Sprague-Dawley rats (body weight: 290g-310g) were obtained from the Experimental Animal Centre of Sichuan University. The rats were housed in a temperature (~22°C) controlled room in which 12h light/dark cycle was maintained. The rats had free access to standard rodent chow and filtered water. After 7 days acclimation, the rats were randomly divided into 4 groups (n=14 each group): (1) sham group, rats were treated with bilaterally intracerebroventricular (ICV) injection of a water/acetonitrile (3:1) mixture; (2) sham+EA group, rats were treated with bilaterally ICV injection of a water/acetonitrile (3:1) mixture and EA treatment; (3) AD group, rats were treated with bilaterally ICV injection of Aβ1-42; (4) AD+EA group, rats were treated with bilaterally ICV injection of Aβ1-42 and EA treatment. The experiments were performed in accordance with the national guidelines for the care and use of laboratory animals and were approved by the Experimental Animal Welfare and Committee of Sichuan University.
Aβ 1-42 oligomerization and AD rat model establishment
Beta-amyloid 1-42 (Aβ 1-42 ), purchased from Abcam, Cambridge, MA, UK, was prepared at a concentration of 10mM in a 3:1 water/acetonitrile mixture, and aliquots were stored at -20°C. The Aβ 1-42 peptide oligomerization or a 3:1 water/acetonitrile mixture was administered by ICV injection, as previously described (20) . Briefly, the rats were anesthetized with chloral hydrate (300mg/kg) via intraperitoneal injection and then placed on a stereotaxic apparatus (DW2000, Taimeng Co., Ltd., Chengdu, Sichuan, China). Burr holes were drilled in the skull on both sides over the lateral ventricles by using the following coordinates: 1.2mm posterior to the bregma, 2.0mm lateral to the sagittal suture, and 3.0mm beneath the surface of the dura. Total volume of 10μl of Aβ 1-42 (10mM) was intracerebroventriculy injected (5μl per lateral ventricle). Body temperature was maintained at 37°C by surface heating/cooling instrument (YGS230-Ⅱ, Shanghai Tianshen Ltd., Shanghai, China).The injection lasted 30min and the needle with the syringe was left in place for 10min after the injection for the completion of drug infusion. After surgery, the scalp was sutured. Penicillin (100,000U) was injected intramuscularly into the gluteus, once a day for 3 days.
EA treatment
EA treatment was performed immediately after Aβ 1-42 ICV injection, according to the method of reference (21) . Briefly, the rats from the sham+EA and AD+EA groups were anesthetized with ethylether to avoid restraint stress. The rats were then stimulated with EA (G6805-Ⅱ EA Instrument, Qingdao Xinsheng Co., Ltd., Qingdao, Shandong, China) at the Baihui acupoint (GV20) and Yongquan acupoints (KI1). The acupoint GV20 is located at the intersection of the sagittal midline and the line linking rat ears, and the acupoints KI1 are located at the center of the palm in posterior limbs. Acupuncture needles (0.18×30mm) were respectively inserted into GV20 and KI1 to a depth of approximately 5mm, then these needles were stimulated at an intensity of 1mA and at a frequency of 2/15Hz, once a day for 30min, lasting for 28 days. During the anesthesia and EA treatment period, the core temperature of rats was maintained at 37.0°C by surface heating or cooling instrument (YGS230-Ⅱ, Shanghai Tianshen Co., Ltd., Shanghai, China). The rats in the sham and AD groups received anesthesia same as in the sham+EA and AD+EA groups, once a day for 28 days.
Morris water maze test
To investigate spatial learning and memory ability, rats were subjected to the Morris water maze (MWM) test, including orientation navigation and space probe trials following 4 weeks of treatment (16, 22) . Briefly, the MWM test was performed in a plastic, circular pool, 1.2m in diameter and 0.5m in height (WMT-100S, Taimeng Co., Ltd., Chengdu, Sichuan, China), which was filled with water (25±2°C) to a depth of 20cm. A circular platform (10cm in diameter) was placed in the fourth quadrant away from the edge of the pool. The top of the platform was submerged 1.5cm below the water surface. Water was made cloudy by adding milk powder. A video camera attached to a computer was placed above the center of the tank to record and analyze the trajectory of the rats (WMT-100S, Taimeng Co., Ltd., Chengdu, Sichuan, China). During the orientation navigation trials, each rat was gently placed in the water at one of the four equidistant locations in a random order. Then, the rat was allowed to swim escaping onto the platform, and the escape latency (the spending time to find the platform) was recorded for 60sec. After 60sec, if the rat failed to find the platform, it was guided to the platform and was allowed to stay on the platform for 20sec.The computer recorded the time it took the rat to find the platform. The orientation navigation trials were performed three trials a day with one starting at 8:00, the other at 14:00 and another at 20:00, and repeated for four days.
On the fifth day, the space probe test was conducted to assess memory consolidation, in which the platform was removed, and the rat was allowed to swim freely for 60sec. The start position was located 180˚ from the original platform position to ensure that the spatial preference was a reflection of the memory of the goal location, rather than for a specific swim path. The swimming time the rats spent in target quadrant were recorded. The percentage of time spent in the target quadrant was used for statistical analysis. After completion of the MWM test, rats in each group were sacrificed to harvest the 
Nissl staining
Rats were deeply anesthetized with 10% chloral hydrate and then fixed by transcardial perfusion with 0.9% NaCl, followed by 4% paraformaldehyde(Sigma, USA). After perfusion, the brain tissues were removed and post-fixed in the same solution at 4°Cfor overnight. Then, the specimens were processed and embedded in paraffin. Transverse serial sections were made and the blocks were cut at intervals of 30μm with 5μm in thickness of each section. For each level, one section was obtained and soaked in 1% toluidine blue (Beyotime, Nanjing, Jiangsu, China) for 3min. Sections were then dehydrated using 95% and 100% ethanol solutions, transparented using xylene, and placed the cover slips. Images were captured using a Mshot color video camera (MD50, China) mounted on an Olympus microscope (CX41, Japan).
Western blot analysis
The total protein of hippocampus was extracted as previously described (23) . Briefly, the hippocampus tissue was homogenized independently in RIPA buffer (Beyotime, Nanjing, Jiangsu, China) with 1% Phenylmethylsulfonyl fluoride (PMSF) and protease inhibitor at 4°C. After centrifugation at 12,000rpm for 10min, the supernatant was collected and quantified by BCA (bicinchoninic acid) Protein Assay Kit (Beyotime, Nanjing, Jiangsu, China) and stored at -80°C. An equal amount of total protein (25mg) was loaded and separated by sodium dodecyl sulfate polyacrylamide gel and then transferred onto polyvinylidenefluoride (PVDF) membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% non-fat milk in TBS-T(10 mmol/L Tris, 150 mmol/L NaCl and 0.1% Tween 20, pH 7.5) for 2h at room temperature, and the membranes were then incubated at overnight with different primary antibodies: mouse NOX2 antibody (1:200; Santa Cruze, USA), rabbit NeuN antibody (1:500; proteintech, Chicago,IL, USA), rabbit β-actin antibody (1:500; proteintech, Chicago,IL, USA). On the following day, the membranes were washed in TBS-T and incubated with the appropriate secondary antibodies conjugated to horseradish peroxidase (HRP) for 1h at room temperature. The target protein bands were visualized with chemiluminescence luminol reagents (ECL; millipore, Billerica, MA, USA). Blots were imaged by Molecular Image ® ChemiDoc TM XRS+with Image Lab TM Software (Bio-Rad, Hercules, CA, USA). Quantitative data were obtained by ImageJ 1.50b Gel Analyzer (National Institutes of Health, Washington, DC, USA). Western blot data were normalized relative to the density of the β-actin bands.
Statistical analysis
All data were expressed as the mean±SD. A multifactorial analysis of variance (ANOVA) for repeated measurement was employed for analyzing escape latencies in the MWM test. One-way ANOVA was employed for analyzing other data followed by LSD (equal variances assumed) or Dunnett's T3 (equal variances not assumed) post hoc test with SPSS 17.0 software package. Statistical significance was set at P<0.05.
hippocampus for pathologic and biochemical analysis.
ROS Staining
ROS levels in the hippocampus were assessed using a ROS Fluorescent Probe-DHE kit (Beyotime, Jiangsu, China) according to the manufacturer's instructions (23) . Briefly, the frozen hippocampus were cut at a thickness of 12μm, and then the sections were incubated with DHE (50μM) in PBS for 10min at 37°C in a humidified chamber protected from light. Fluorescent images were captured with a fluorescence microscope (Olympus, Tokyo, Japan). The ROS positive cells in hippocampus of each section were visualized following reaction with DHE, then using DAPI to visualize nuclei of all cells. The image selected for calculation of DHE-positive cells is 313×233μm 2 obtained by microscopy(LEICA, DFC310 FX) with a high-power lens(400×magnification).
Immunofluorescence staining
Rats were deeply anesthetized with 10% chloral hydrate (3ml/kg body weight, i.p.) and then fixed by transcardial perfusion with 0.9% NaCl, followed by 4% paraformaldehyde(Sigma, USA) and then the hippocampus were cut in 12μm sections. Subsequently, the sections were immersed in 0.3% H 2 O 2 in methanol for 15min and then incubated with 10% normal goat serum for 30min. Afterwards, sections were incubated with primary antibodies: rabbit anti-neuron (1:200; Abcam, Cambridge, MA, UK), mouse anti-NOX2/ gp91phox (1:200; Santa Cruz, USA) and mouse anti-8-hydroxy-2'-deoxyguanosine (8-OH-dG; 1:200; Santa Cruz, CA, USA) in 1% BSA at 4°C overnight in a humidified chamber. Following three washes with PBS, sections were then incubated with goat anti-rabbit IgG-FITC (1:600; proteintech, Chicago, IL, USA), donkey anti-mouse IgG-Cy3 (1:800; Abcam, Cambridge, MA, UK) and goat anti-mouse IgG-Cy3 (1:600; proteintech, Chicago, IL, USA) for 1h at room temperature. After washing out the secondary antibodies, sections were incubated with 4, 6-diamidino-2-pheny-lindole (DAPI; sigma, MO, USA) for nuclear staining. Fluorescent images were captured with a fluorescence microscope (Olympus, Tokyo, Japan). 8-OH-dG-positive cells were counted sham as the method mentioned in the section of ROS Staining.
MDA content and total antioxidant capacity assay
Lipid peroxidation was evaluated by malondialdehyde (MDA) assay kit (Jiancheng institute of biological engineering, Nanjing, Jiangsu, China) according to the manufacturer's instructions. Briefly, the hippocampus tissue was homogenized independently and centrifuged at 3500rpm for 10min. The supernatant was collected and incubated with MDA reaction solution and then measured by spectrophotometry at 532nm (24) .
Total antioxidant capacity (T-AOC) was evaluated by T-AOC assay kit (Jiancheng institute of biological engineering, Nanjing, Jiangsu, China) according to the manufacturer's instructions. Briefly, the hippocampus tissue was homogenized independently and fully blending and keeping still for 10min.The supernatant was collected and was measured by spectrophotometry at 520nm.
Results
EA treatment ameliorates spatial learning and memory impairment induced by Aβ 1-42 in rats
To determine whether EA treatment could ameliorate spatial learning and memory impairment in AD rats, MWM test was applied and the results were shown in Figure 1 . During the training period, the escape latency of all the tested rats was getting shorter and shorter as the learning proceeding. However, the escape latency of the rats in the AD group was consistently longer compared with those in the sham group (AD: 33.59±2.455s vs. sham: 18.14±2.064s, P<0.05), whereas EA treatment obviously decreased the escape latency of the AD rats (AD+EA: 19.09±3.493s vs. AD: 33.59±2.455s, P<0.05). In addition, there was not significantly different in escape latency between the sham and sham+EA groups (sham: 18.14±2.064svs. sham+EA: 17.33±1.866s, P>0.05; Figure 1A and 1B) . In the space probe test, after removed the platform, the AD rats spent less time swimming in the target quadrant compared with those in the sham group (AD: 27.10±3.795% vs. sham: 38.28±4.496%, P<0.05). However, the rats in the AD+EA group spend more time swimming in the target quadrant than those in the AD group (AD+EA: 37.19±2.539% vs. AD: 27.10±3.795%, P<0.05). No significant difference was observed in the percentage of swimming time spent in the target quadrant between the sham and sham+EA groups(sham: 38.28±4.496%; sham+EA vs. 40.22±2.250%,P>0.05; Figure 1C and 1D). Thus, EA treatment could ameliorate the spatial learning and memory impairment induced by Aβ 1-42 in rats.
EA treatment attenuates oxidative stress induced by Aβ 1-42 in rats
To explore whether EA treatment could attenuate oxidative stress in AD rats, the ROS was evaluated by using ROS Fluorescent Probe-DHE ( Figure 2A) . As illustrated in Figure 2B , the number of DHE-positive cells were strikingly increased in the AD group compared with the sham group (AD: 45.83±2.137 vs. sham: 13.50±1.871, P<0.05), whereas the increased DHE-positive cells due to Aβ 1-42 injection was decreased in the AD+EA group compared with the AD group (AD+EA:15.83±3.061 vs. AD:45.83±2.137, P<0.05). In addition, the number of DHE-positive cells in sham group did not differ significantly from the sham+EA groups (sham: 13.50±1.871 vs. sham+EA: 13.17±2.137, P>0.05).
Immunofluorescence staining revealed low levels and sparsely distributed 8-OH-dG immunoreactivity in the hippocampus of the sham rats ( Figure 3A) . In contrast, the 8-OH-dG immunoreactivity in the hippocampus in AD rats was strikingly increased. There was no identifiable difference in 8-OH-dG immunoreactivity in the hippocampus between the sham and AD+EA rats. As illustrated in Figrue 3B,the number of 8-OH-dG-positive cells was significantly increased in the AD group compared with sham group (AD: 8.00±2.191 vs. sham: 2.00±0.632, P<0.05). However, the number of 8-OH-dG-positive cells in the AD+EA group was significantly lower than that in the AD group (AD+EA: 3.00±0.632 vs. AD: 8.00±2.191, P<0.05). In addition, the difference in number of 8-OH-dG-positive cells had no statistical significance between the sham and sham+EA groups (sham: 2.00±0.632 vs. sham+EA : 2.17±0.753, P>0.05).
To further confirm the effects of EA treatment on lipid peroxidation induced by Aβ 1-42 injection, the MDA content was measured ( Figure 4A ). The MDA content was significantly increased in the AD group compared with the sham group (AD: 4.71±0.595nmol/mg prot vs. sham: 1.61±0.191nmol/mg prot, P<0.05). With EA treatment, however, the MDA content was significantly decreased in the EA+AD group compared with the AD group (EA+AD: 1.90±0.210nmol/mg prot vs. AD: 4.71±0.595nmol/mg prot, P<0.05). Moreover, the MDA contents did not vary significantly between the sham and sham+EA groups (sham: 1.61±0.191nmol/mg prot vs. sham+EA: 1.57±0.255nmol/mg prot, P>0.05).
In order to determine whether EA treatment could improve the anti-oxidative ability in AD rats, the T-AOC was assessed and the results were illustrated in Figure 4B . As compared to the sham group, the T-AOC was significantly decreased in the AD group (sham: 0.91±0.115U/mg prot vs. AD: 0.50±0.118U/mg prot, P<0.05). In response to EA treatment, the T-AOC was strikingly increased (AD+EA: 0.82 ±0.116U/mg prot vs. AD:0.50±0.118U/mg prot, P<0.05). No significant difference was observed in T-AOC between the sham and sham+EA groups (sham:0.91±0.115U/mg prot vs. sham+EA:0.92±0.110U/mg prot, P>0.05). Taken together, EA treatment attenuates Aβ 1-42 -induced oxidative stress in rats.
EA treatment ameliorates neuronal injury and sup-pressesNOX2 expression in AD rats
To explore the possible mechanisms of EA treatment improved spatial learning and memory deficits in AD rat, the neuronal degeneration was detected by Nissl staining (Figure 5A ). The neurons in the hippocampus of the sham and sham+EA groups exhibited normal shapes and deeply stained Nissl bodies. In the AD group, some of the neurons in the hippocampus became severely swollen and exhibited weakly stained Nissl bodies. With EA treatment, the swelling of neurons and Nissl bodies were obviously alleviated and stained more deeply in the AD+EA group.
The distribution of NOX2 was examined by doublelabel immunofluorescent staining of NOX2 and NeuN. As illustrated in Figure 5B , almost all the neurons expressed NOX2 in AD group when compared to the sham group. With EA treatment, the neurons with NOX2 and NeuN co-localization were markedly decreased in the AD+EA group. Quantitative analysis of the expression of NOX2 ( Figure 5C ) indicated that the level of NOX2 in the AD group was significantly increased compared with the sham group (AD: 1.14±0.052 vs. sham: 0.64±0.032, P<0.05). EA treatment significantly decreased the level of NOX2 in the AD+EA group compared to the AD group (AD+EA: 0.69±0.032 vs.AD: 1.14±0.052, P<0.05). Moreover, no significant difference in NOX2 expression was found between the sham and sham+EA groups (sham: 0.64±0.032 vs. sham+EA: 0.65 ±0.033, P<0.05). In contrast, the level of NeuN ( Figure 5D ) was significantly decreased in the AD group compared with that in the sham group (AD: 0.71±0.054 vs. sham: 0.99±0.051, P<0.05), whereas EA treatment strikingly increased the level of NeuN in the AD+EA group compared to the AD group (AD+EA: 0.94±0.071;AD: 0.71±0.054; P<0.05). These results demonstrated that EA treatment decreases NOX2 and increases NeuN expression in AD rats. 
Discussion
The results presented in this study suggested that GV20 and KI1EA stimulation could improve spatial learning and memory deficits induced by Aβ 1-42 in rats. Staining of DHE revealed that EA treatment effectively decreased ROS production in the hippocampus of AD rats, which was accompanied by a reduction of MDA and 8-OH-dG expression. Furthermore, the T-AOC was restored in the AD rats following EA treatment. More notably, EA treatment also attenuated neuronal injury, decreased the number of NOX2(+)/NeuN(+) cells and down-regulated NOX2 expression in AD rats. Our findings demonstrated that EA treatment could ameliorate spatial learning and memory impairment induced byAβ in rats, which might be associated with attenuation of neuronal degeneration in AD rats through inhibition of NOX2-related oxidative stress.
Experimental models of AD are essential to gaining a better understanding of pathogenesis and to perform preclinical testing of novel therapeutic approaches. Based on our research data and previous studies, it is recognized that the soluble Aβ oligomers rather than the final plaques may possess more severe neurotoxicity, since it is more likely to cause cognitive deficits in AD patients (25) . Therefore, the rats subjected to intracerebroventricular injection of Aβ1-42 may be seen as an alternative to transgenic animals to study the AD mechanism, despite the fact that there is no presence of plaques in the brain of the model animals (26) . Additionally, accumulating evidence showed that administration of soluble Aβ in mice/rats could induce cognitive deficits, inhibit LTP, and result in oxidative stress and neuronal loss hippocampus (27) (28) (29) . Thus, we tended to choose this type of AD model in the current study.
Acupuncture therapy is a vital part of traditional medicine, and it has been shown to have significant clinical effects in the treatment of various diseases in Asia.
A number of studies have demonstrated that the functions of the GV20 and KI1 acupoints in rats have similar physiological functions to those defined in patients. For example, some researches have conducted studying the effects of EA on GV20 and KI1 in treating cognitive impairment in rats, and several beneficial outcomes have been observed, including protection of neurological function by increased the expression of Bcl-2 and activation of the CREB signaling pathway (30) , improved learning and memory performance via ameliorating the synaptic plasticity and efficiency of the excitatory synaptic transmission (31) , decreased the activated glial cells (32) , and attenuation of neuronal damage induced by hyper-gravity in rats (33) , these results consistent with reports in the human (34, 35) . . In the present study, with a widely used MWM test, we found that the spatial learning and memory abilities of rats in the EA+AD group were significantly improved compared to the AD group. Thus, this evidence suggested that EA treatment could effectively improve the learning and memory deficits induced by Aβ 1-42 in rats, which was consistent with previous research (12, 32) .
ROS overproduction and oxidative stress have been proposed to play a critical role in AD (36) . When ROS overwhelm the cellular antioxidant defense system, or a decrease in the cellular antioxidant capacity, oxidative stress occurs (37) . Previous studies revealed that ROS is an instigator in Aβ production, which contributes to the characteristic neurodegeneration of AD (38, 39) . We found that Aβ 1-42 injection significantly increased the ROS level in the hippocampus of AD rats, and EA treatment had good alleviative effects. Several lines of evidence suggest that oxidative stress occurs in very early stages of AD ahead of massive Aβ deposits (26) . The accumulated evidence indicate that oxidative stress not only damages essential cellular constituents such as lipids, proteins and nucleic acids, but also can decompose these products (40) .The amounts of MDA often reflect the degree of lipid peroxidation in tissue and thus indirectly reflect the degree of cell damage (2). 8-OH-dG is one of the most sensitive DNA damage markers, and is produced following hydroxyl radical induction during oxidative stress (23) . In this study, we found increase of MDA and 8-OH-dG expression in the hippocampus of AD rats, suggesting that oxidative stress occurs as a consequence of AD, there by potentially inducing spatial learning and memory deficit in AD rats. EA treatment notably decreased the accumulation of MDA and 8-OH-dG levels in the hippocampus of AD rats. T-AOC is an indicator of total intracellular antioxidant status, which indirectly reflect cell damage, and can be used to determine the degree of cell damage (41) . In this study, we found that EA treatment strikingly increased the T- AOC in the hippocampus of AD rats, suggesting that EA treatment attenuates oxidative stress induced by Aβ 1-42 in rats. In this context, EA treatment has been shown to have antioxidant effects and to potentially improve spatial memory impairment.
The present study also demonstrated the neuoprotective effect of EA treatment based on the histopathological status of neurons in the hippocampus of AD rats. Nissl bodies are clumps of rough endoplasmic reticulum which are involved in the synthesis of proteins. Thus, staining of Nissl bodies is often used to reflect the functional status of neurons (42) . We found that Nissl bodies of the neurons in the hippocampus of AD rats were deeply stained in sham rats. However, some of the neurons became swollen, and Nissl bodies were collapsed and stained lightly in the rats with Aβ 1-42 injection. After EA treatment, neuronal swelling became milder, and Nissl bodies were more deeply stained. These results suggest that EA treatment plays a significant role in alleviating neuronal injury induced by Aβ 1-42 in rats.
In order to investigate the mechanism of the neuroprotective action of EA, we examined the expression of NOX2. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) are a family of enzymes that lead to the generation of ROS (5) . It has been reported that gp91phoxis the catalytic subunit of NOX2.The activity of gp91phox is strongly associated with ROS production (23) . Previous studies showed that EA treatment increased the activation of anti-oxidant enzymes (43) , and attenuated brain injury through inhibition of NOX2 expression (23) . In this study, the expression of gp91phox together with ROS production induced by Aβ 1-42 injectionis suppressed significantly by EA treatment. Our results were supported by a recent report that have been shown EA pretreatment inhibited NOX-mediated oxidative stress in mice with ischemic stroke (44) . Thus, these results suggest that decreasing ROS generation with suppressing NOX2 expression is the possible mechanism of EA treatment to improve learning and memory impairment induced by Aβ 1-42 in rats.
In the present study, we only used Water maze test to assess learning and memory ability of rats. Previous research suggested that the Y-maze test is also a suitable method to evaluate the spatial learning and memory function of rats (26) . In addition, we only detected the neurons in the hippocampus, however, the presence and structure of glial cells and other associated proteins was not assessed. Therefore, the interpretation of the data is restricted by these limitations in the study design. However, the overall pattern in the data remains clear and the limitations will be addressed and improved in subsequent studies. Although more studies are still needed to fully elucidate the involvement of molecular signal pathways, our results strongly demonstrate that EA treatment can improve spatial learning and memory impairment via inhibition of NOX2-related oxidative stress and alleviation of neuronal injury in Aβ 1-42induced AD rats. Our findings also suggest that EA at the GV20 and KI1 acupoints may serve as a promising strategy for AD treatment.
